Document Detail


Atypical antipsychotics and pituitary neoplasms in the WHO database.
MedLine Citation:
PMID:  17285098     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Amisulpride and risperidone are potent dopamine D2 receptor blocking atypical antipsychotics that can cause hyperprolactinemia. Preclinical evidence shows that chronic administration of antipsychotics can cause pituitary adenomas in female mice. To investigate the clinical relevance in this finding, reports of pituitary neoplasms in the WHO adverse drug reaction (ADR) database were reviewed. Amisulpride and risperidone [corrected] had among the highest Information Component (IC) scores for benign pituitary neoplasm; amisulpride (IC = 3.31, IC025 = 1.83, 5 reports) and risperidone (IC = 4.03, IC025 = 3.33, 19 reports), and not otherwise specified (NOS) pituitary neoplasm: amisulpride (IC = 2.69, IC025 = 0.70, 3 reports) and risperidone (IC = 4.49, IC025 = 3.86, 23 reports). We conclude that there is a need for prospective studies to confirm causality and suggest that clinicians, until then, would consider a pituitary adenoma in patients experiencing severe hyperprolactinemia or associated symptoms when receiving potent D2 antagonists [corrected]
Authors:
P Murali Doraiswamy; Gisela Schott; Kristina Star; Ralph Edwards; Bruno Mueller-Oerlinghausen
Related Documents :
16024948 - Hyperparathyroidism accompanying multiple myeloma.
4026668 - Clostridium difficile colitis following head and neck surgery. report of cases.
15333668 - Ciliary body adenoma of non-pigmented epithelium.
2696928 - Severe pseudomembranous enterocolitis in a child: case report and literature review.
9049898 - Brainstem abscess: preoperative mri appearance and survival following stereotactic aspi...
7465258 - Adult non-endemic burkitt's lymphoma. an australian case report.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Psychopharmacology bulletin     Volume:  40     ISSN:  0048-5764     ISO Abbreviation:  Psychopharmacol Bull     Publication Date:  2007  
Date Detail:
Created Date:  2007-02-07     Completed Date:  2007-05-02     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0101123     Medline TA:  Psychopharmacol Bull     Country:  United States    
Other Details:
Languages:  eng     Pagination:  74-6     Citation Subset:  IM    
Affiliation:
Department of Psychiatry and the Department of Medicine at Duke University Medical Center, DUMC 3018, Durham, NC 27514, USA. dorai001@mc.duke.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenoma / chemically induced*,  epidemiology
Adult
Adverse Drug Reaction Reporting Systems
Antipsychotic Agents / adverse effects*,  therapeutic use
Causality
Female
Humans
Male
Pituitary Neoplasms / chemically induced*,  epidemiology
Risk
Risperidone / adverse effects*,  therapeutic use
Schizophrenia / drug therapy*,  epidemiology
Sulpiride / adverse effects,  analogs & derivatives*,  therapeutic use
World Health Organization
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 106266-06-2/Risperidone; 15676-16-1/Sulpiride; 53583-79-2/sultopride
Comments/Corrections
Erratum In:
Psychopharmacol Bull. 2007;40(2):5

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Citalopram versus amitriptyline in elderly depressed patients with or without mild cognitive dysfunc...
Next Document:  Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicia...